The open targets post-GWAS analysis pipeline
Peat, Gareth, Jones, William, Nuhn, Michael, Marugán, José Carlos, Newell, William, Dunham, Ian, Zerbino, Daniel
Published in Bioinformatics (01.05.2020)
Published in Bioinformatics (01.05.2020)
Get full text
Journal Article
CIEMAT experimental proposal on lithium ignition in support of DONES licensing (LiFIRE facility)
D'Ovidio, Gianluca, Martín-Fuertes, Francisco, Alegre, Daniel, Marugán, Juan Carlos, Pitigoi, Adrián, Sierra, Javier, Molla, Joaquín
Published in Nuclear materials and energy (01.06.2022)
Published in Nuclear materials and energy (01.06.2022)
Get full text
Journal Article
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Gong, Xueqian, Litchfield, Lacey M., Webster, Yue, Chio, Li-Chun, Wong, Swee Seong, Stewart, Trent R., Dowless, Michele, Dempsey, Jack, Zeng, Yi, Torres, Raquel, Boehnke, Karsten, Mur, Cecilia, Marugán, Carlos, Baquero, Carmen, Yu, Chunping, Bray, Steven M., Wulur, Isabella H., Bi, Chen, Chu, Shaoyou, Qian, Hui-Rong, Iversen, Philip W., Merzoug, Farhana F., Ye, Xiang S., Reinhard, Christoph, De Dios, Alfonso, Du, Jian, Caldwell, Charles W., Lallena, María José, Beckmann, Richard P., Buchanan, Sean G.
Published in Cancer cell (11.12.2017)
Published in Cancer cell (11.12.2017)
Get full text
Journal Article
Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene
Gong, Xueqian, Du, Jian, Parsons, Stephen H, Merzoug, Farhana F, Webster, Yue, Iversen, Philip W, Chio, Li-Chun, Van Horn, Robert D, Lin, Xi, Blosser, Wayne, Han, Bomie, Jin, Shaoling, Yao, Sufang, Bian, Huimin, Ficklin, Chris, Fan, Li, Kapoor, Avnish, Antonysamy, Stephen, Mc Nulty, Ann M, Froning, Karen, Manglicmot, Danalyn, Pustilnik, Anna, Weichert, Kenneth, Wasserman, Stephen R, Dowless, Michele, Marugán, Carlos, Baquero, Carmen, Lallena, María José, Eastman, Scott W, Hui, Yu-Hua, Dieter, Matthew Z, Doman, Thompson, Chu, Shaoyou, Qian, Hui-Rong, Ye, Xiang S, Barda, David A, Plowman, Gregory D, Reinhard, Christoph, Campbell, Robert M, Henry, James R, Buchanan, Sean G
Published in Cancer discovery (01.02.2019)
Published in Cancer discovery (01.02.2019)
Get full text
Journal Article
TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling
Marugán, Carlos, Sanz‐Gómez, Natalia, Ortigosa, Beatriz, Monfort‐Vengut, Ana, Bertinetti, Cristina, Teijo, Ana, González, Marta, Alonso de la Vega, Alicia, Lallena, María José, Moreno‐Bueno, Gema, Cárcer, Guillermo
Published in Molecular oncology (01.06.2024)
Published in Molecular oncology (01.06.2024)
Get full text
Journal Article
Implementation of Safety Aspects in IFMIF-DONES Design
Martín-Fuertes, Francisco, Marugán, Juan Carlos, García, Antonio, Pinna, Tonio, Qiu, Yuefeng, Helminen, Atte, Potempski, Slawomir, Gallego, Eduardo, Ogando, Francisco, D’Ovidio, Gianluca, Pérez, Manuel, Ibarra, Ángel
Published in Journal of Nuclear Engineering (01.12.2022)
Published in Journal of Nuclear Engineering (01.12.2022)
Get full text
Journal Article
Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives
Marugán, Carlos, Torres, Raquel, Lallena, María José
Published in Frontiers in oncology (07.01.2016)
Published in Frontiers in oncology (07.01.2016)
Get full text
Journal Article
Abemaciclib, a CDK4 and 6 inhibitor with unique pharmacological properties for breast cancer therapy
Torres-Guzmán, Raquel, Ganado, Maria Patricia, Mur Pérez, Cecila, Marugán, Carlos, Baquero, Carmen, Yang, Yanzhu, Du, Jian, de Dios, Alfonso, Puig, Oscar, Lallena, Maria Jose
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Abstract 4850: Targeting prostate cancer with the CDK4 and CDK6 inhibitor abemaciclib
Torres-Guzmán, Raquel, Baquero, Carmen, Ganado, Maria Patricia, Marugán, Carlos, Bian, Huimin, Zeng, Yi, Rama, Ramón, Du, Jian, Lallena, Maria José
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
The LiFIRE experimental facility: Final design, construction and experimental campaign
D'Ovidio, Gianluca, Martín-Fuertes, Francisco, Alegre, Daniel, Mollá, Joaquín, Brañas, Beatriz, Gutiérrez, Víctor, Villamayor, Víctor, Marugán, Juan Carlos, Gallo, Javier, Fernández, Antonio, Campa, Paula de la, Mirapeix, Fernando, Ibarra, Ángel
Published in Fusion engineering and design (01.04.2024)
Published in Fusion engineering and design (01.04.2024)
Get full text
Journal Article
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation
Torres-Guzmán, Raquel, Ganado, Maria Patricia, Mur, Cecilia, Marugan, Carlos, Baquero, Carmen, Yang, Yanzhu, Zeng, Yi, Bian, Huimin, Du, Jian, de Dios, Alfonso, Puig, Oscar, Lallena, María José
Published in Oncotarget (02.07.2022)
Published in Oncotarget (02.07.2022)
Get full text
Journal Article
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy
Du, Jian, Yan, Lei, Torres, Raquel, Gong, Xueqian, Bian, Huimin, Marugán, Carlos, Boehnke, Karsten, Baquero, Carmen, Hui, Yu-Hua, Chapman, Sonya C, Yang, Yanzhu, Zeng, Yi, Bogner, Sarah M, Foreman, Robert T, Capen, Andrew, Donoho, Gregory P, Van Horn, Robert D, Barnard, Darlene S, Dempsey, Jack A, Beckmann, Richard P, Marshall, Mark S, Chio, Li-Chun, Qian, Yuewei, Webster, Yue W, Aggarwal, Amit, Chu, Shaoyou, Bhattachar, Shobha, Stancato, Louis F, Dowless, Michele S, Iversen, Phillip W, Manro, Jason R, Walgren, Jennie L, Halstead, Bartley W, Dieter, Matthew Z, Martinez, Ricardo, Bhagwat, Shripad V, Kreklau, Emiko L, Lallena, Maria Jose, Ye, Xiang S, Patel, Bharvin K R, Reinhard, Christoph, Plowman, Gregory D, Barda, David A, Henry, James R, Buchanan, Sean G, Campbell, Robert M
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Abstract 1852: Combination of the CDK4/6 inhibitor abemaciclib with xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, results in synergistic antineoplastic effects in human breast cancer cell lines
Weyer-Czernilofsky, Ulrike, Baumgartinger, Rosa, Schmittner, Susanne, Gong, Xueqian, Buchanan, Sean, Beckmann, Richard P., Marugan, Carlos, Torres, Raquel, Boehnke, Karsten, Lallena, Maria Jose, Solca, Flavio, Kraut, Norbert, Bogenrieder, Thomas
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract LB-318: Characterization of the mechanism of action of abemaciclib in NSCLC cell lines harboring KRAS mutation
Torres-Guzmán, Raquel, Baquero, Carmen, Marugan, Carlos, Mur, Cecilia, Gharbi, Severine I., Gomez, Sandra, Amat, Joaquín, Boehnke, Karsten, Iversen, Philip W., deDios, Alfonso, Gong, Xueqian, Buchanan, Sean, Beckman, Richard P., Lallena, Maria José J.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article